Instructions for Rederm (salicylic acid, betamethasone) ointment
English product name,
Rederm
Release Form Rederm
ointment d/external approx. 0.5 mg+30 mg/1 g: tubes 15 g or 30 g
Description
Ointment for external application of almost white color, translucent, homogeneous.
1g
betamethasone (in the form of betamethasone dipropionate) 0.5 mg
salicylic acid 30 mg
Auxiliary substances: paraffin liquid (mineral oil), paraffin white soft (white petrolatum).
15 g - aluminium tubes (1) - cardboard packs.
30 g - aluminium tubes (1) - cardboard packs.
ATC codes
D07XC01 Betamethasone in combination with other drugs
Clinical-pharmacological groups / Group affiliation
Preparation with anti-inflammatory and keratolytic effect for external use
Active substance Rederm
- salicylic acid
- betamethasone (in the form of dipropionate)
Pharmaco-therapeutic group Rederm
Glucocorticosteroid for local use+keratolytic agent
Storage Conditions
The drug should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.
Best before date
The shelf life is two years. Do not apply after expiry date.
Pharmacological effect Rederm
A combined preparation for external use, the effect of which is determined by the components contained therein. It has an anti-inflammatory, anti-allergic, anti-inflammatory, keratolytic effect.
Betamethasone inhibits the release of inflammation mediators, prevents the edge cluster of neutrophils, reduces inflammatory exudate and cytokine production, reduces macrophage migration, resulting in a reduction in infiltration and granulation processes.
The presence of salicylic acid softens the skin, eliminates horny layers and contributes to a deeper penetration of betamethasone.
Testimony Rederm
- Treatment of subacute and chronic dermatoses accompanied by hyperkeratosis and exfoliation:
- psoriasis;
- Dihydrotic dermatitis;
- eczema;
- neurodermit;
- Red flat fox;
- ichthyosis and ichthyosis skin lesions;
- atopic dermatitis;
- diffuse neurodermite;
- simple and allergic dermatitis;
- urticaria;
- multidimensional exudative erythema;
- simple chronic lychee (limited neurodermatitis);
- Dermatoses that cannot be treated by other GCS (especially red, bearded lychee);
- skin dyshidrosis.
Method of use, course and dosage
The preparation is used externally. Apply on affected skin areas in the following way: a column of ointment of 0.5 cm long on a skin area of approximately 7×7 cm, rubbing slightly, with a thin layer twice daily. Another frequency of use can be established by a doctor based on the severity of the disease.
In mild cases, ointment is sufficient, usually once a day; for more severe lesions, more frequent use may be necessary.
If necessary, occlusion bandages are applied, which change every 24 hours.
The duration of treatment depends on the effectiveness and tolerability of the therapy and is two to four weeks.
If there is no clinical improvement, the diagnosis should be clarified.
- Nosology (ICD codes)
- L20.8
- Other atopic dermatitis (neurodermatitis, eczema)
- L23
- Allergic contact dermatitis
- L24
- Simple Irritable [irritant] Contact Dermatitis
- L28.0
- Simple chronic lychee (limited neurodermatitis)
- L30.0
- Monetoid eczema
- L30.1
- Dyhydrosis [Pompholics]
- L40
- Psoriasis
- L43
- Lishay red flat
- L43.0
- Lishay hypertrophic red flat
- L50
- Urticaria
- L51
- Erythema polyforma
- L85.0
- Acquired ichthyosis
- R23
- Other skin changes